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Abstract
Background: Implementation of clinical research results is challenging, yet the responsibility for implementation is
seldom addressed. The process from research to the use of clinical research results in health care can be facilitated
by research funders. In this paper, we report the roles of ten Swedish research funders in relation to implementation
and their views on responsibilities in implementation.
Findings: Ten cases were studied and compared using semi-structured interviews. In addition, websites and key
documents were reviewed. Eight facilitative roles for research funders in relation to the implementation of
clinical research results were identified. Three of them were common for several funders: “Advocacy work,”
“Monitoring implementation outcomes,” and “Dissemination of knowledge.” Moreover, the research funders
identified six different actors responsible for implementation, five of which belonged to the healthcare setting.
Collective and organizational responsibilities were the most common forms of responsibilities among the
identified actors responsible for implementation.
Conclusions: The roles commonly identified by the Swedish funders, “Advocacy work,” “Monitoring implementation
outcomes,” and “Dissemination of knowledge,” seem feasible facilitative roles in relation to the implementation of clinical
research results. However, many actors identified as responsible for implementation together with the fact that collective
and organizational responsibilities were the most common forms of responsibilities entail a risk of implementation
becoming no one’s responsibility.
Keywords: Quality improvement, Implementation responsibility, Support of research, Research funder roles
Background
Each year, research funders allocate large resources to
universities which study and develop medical treatments.
Implementation is in turn the process whereby the out-
put of these studies is introduced in health care to im-
prove patient care. The output implemented consists of
new treatments, often, in the form of clinical guidelines,
which in turn are based on state-of-the-art reviews [1].
Such reviews are often a combination of several clinical
research studies summarized into recommendations, but
in the essence, the output consists of clinical research
results, i.e., results from research that involves human
subjects or specimen in developing and testing new
treatments to improve patient care [2]. However, the im-
plementation of clinical research results is inadequate,
and there is a wide knowledge-practice gap implying that
patients do not receive optimal care [3]. Much focus to
date has been on healthcare practitioners’—the know-
ledge users—role in implementation [4]. Factors such as
healthcare practitioners’ existing attitudes and skills have
been identified to hinder the behavior change needed to
adopt the new treatments [5]. In a comprehensive re-
view, Flottorp et al. identified 57 barriers and facilitators
for implementation at seven different levels, many of
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which had to do not only with healthcare practitioners
but also with the evidence/clinical research results, the
providing organization, and the surrounding society [6].
Consequently, implementation is a complex process that
aims to change the behavior of healthcare practitioners
in order to improve patient care. However, as implemen-
tation takes place in a wider socio-economic-political
context, the science of implementation can be developed
further if alternative approaches are utilized to study the
knowledge-practice gap [7].
Such an alternative line of enquiry consists of expanding
the focus from healthcare providers to also studying the
effects of including other actors who, although more dis-
tant from practice, can influence the implementation of
clinical research results. More precisely, we argue that
research funders (hereafter funders), who decide over re-
source allocation, may play an important role in the im-
plementation of clinical research results by facilitating the
steps leading to implementation and implementation it-
self. Traditionally, funders’ roles consist of (a) receiving
grant applications, (b) evaluating them, (c) funding the
most suitable ones, and (d) evaluating research outputs
[8]. Thus, funders have traditionally not been interested in
the practical effects of clinical research results [9]. How-
ever, new funder roles are emerging, pushed forward by
the funders of funders—often governments—concerned
by the fact that resources invested in research are not
matched by improvements in public health [10, 11]. These
roles can be termed facilitative and are defined in this
paper as activities that go beyond the four traditional tasks
above (roles a–d) and deal with activities that are relevant
for implementation. Previous studies have recognized sev-
eral facilitative roles for funders: involvement in imple-
mentation of innovations in health care [12], advocating
for the use of research results [11], managing implementa-
tion programs [10], creating interaction between re-
searchers and research users [13, 14], demanding that
researchers submit an implementation plan together with
their grant application [12], and disseminating research
findings [15].
Earlier studies often limit themselves to cases of
single funders [10, 11, 13, 15], although a couple of
exceptions exist, which are international mapping
studies focusing on health research funders efforts
and interest to contribute to improved the use of re-
search results in practice [16, 17]. These studies iden-
tified differences on how various funders defined
their efforts and the extent to which they engaged in
these activities [16, 17]. Despite this, there is a dearth
of studies that more systematically investigate the
perceptions of funders and their facilitative roles in
relation to implementation.
Although the focus in this paper is on funders, it
should be highlighted that the users of clinical research
results are the healthcare practitioners and in some
cases, implementation of new clinical research results
might not be appropriate, e.g., if the evidence base is
too thin [3] or in the case the old treatments need to
be de-implemented first [18]. However, even if the clin-
ical research results are convincing and clearly point at
a need for implementation, implementation does not
happen automatically. Implementation needs initiators,
facilitators, and persons responsible for it. To this end,
the emerging facilitative roles of funders require that
the funders have knowledge in implementation [19] and
an understanding of who is responsible for implementa-
tion [10]. Responsibility for implementation of clinical re-
search results is seldom made explicit and problematized,
and funders’ knowledge about implementation responsi-
bilities is, to the best of our knowledge, not addressed.
Against this background, our aims are (1) to identify the
facilitative roles of ten Swedish funders of clinical research
in relation to implementation and (2) to analyze the fun-
ders’ views about implementation responsibilities.
Findings
Theoretical starting point to study responsibilities
The responsibility for implementation is a problem-
atic issue, as suggested by the “problem of many
hands.” This theory is presented below and high-
lights a set of difficulties related to implementation.
In complex healthcare organizations, where many
different hierarchical levels and actors participate,
the “problem of many hands” implies that it might
be difficult to state who actually is responsible for
implementation [20]. More specifically, the responsi-
bility might be divided between or found at two dif-
ferent levels: the organizational [21] and the personal
levels [22]. Organizational responsibility means that
the organization as a whole takes responsibility whereas
personal responsibility can be divided into three strains: (a)
“Hierarchical,” whereby it is the highest-ranked person—the
director of the healthcare organization—who should take
responsibility, (b) “Collective,” whereby all involved person-
s—e.g., a team of healthcare professionals—should take re-
sponsibility, and (c) “Individual,” whereby each person—an
individual healthcare professional—takes responsibility.
Consequently, the problem of “many hands” indicates
that it might be difficult to state who or which col-
lective actually is responsible and that the different
levels of responsibilities might hinder responsibility
taking, for instance, collective responsibility might en-
tail that implementation becomes no one’s responsibil-
ity [23]. In this paper, the “problem of many hands”
guided the research concerning implementation re-
sponsibilities and was used to analyze findings regard-
ing responsibilities.
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Methods
Ten cases were studied and compared with the help of 18
semi-structured interviews. The ten cases were selected in
order to capture a representative sample of Swedish
funders funding clinical research in terms of the size of
funding, geographical scope, and type of funders (Table 1).
The ten funders’ represent three different levels in the
research funding system: (1) national public funding, (2)
national, private non-profit funding, and (3) local public
funding (see Additional file 1).
The same interview guide was used with all respondents
with minor adaptations to suit funders’ organization and
respondent’s position (see Additional file 2). No specific
definition of the primary concepts discussed in this paper
concerning roles and responsibilities was provided to re-
spondents as exploring their opinions, instead of forcing
them to use specific concepts, was preferred. In order to
diminish bias, methodological triangulation [24] was used
through data collected from websites, annual reports, and
goal statements (Table 2).
The data was analyzed using an abductive approach
[25], which is a suitable approach when one aims to
study phenomena in their context starting from existing
theory [26]. Both “within-cases” and “across-cases” ana-
lyses [27] were conducted. For a more detailed descrip-
tion of the methods used in this study, see Additional
file 3.
Roles and responsibilities in implementation
The three tables (3–5) below indicate our findings show-
ing which level the funder represents (national public,
national private, or local public). The three tables allow
for following the analysis both within the same level of
funders if read vertically and between different levels of
funders if read horizontally.
Table 1 Characteristics of the selected research funders
Funders Function and mission Type of research funded Resourcesa Geographical
scope and type
1. The Education Council Prepares decisions for funding by
government
All main types of research (medical, social
science, technology, natural sciences)
370 million
Euros
National and
public
Debates issues regarding allocation
of public research funds
2. The Research Council for
Medicine and Health
Funds basic and applied research Medical (including clinical) odontological,
pharmacological, care scienceb
32 million
Euros
National and
public
Specific focus on medicine and
health
3. Sweden’s Innovation Agency
(Vinnova)
Funds applied research Clinical, biomedical, health services,
pharmacological
30 million
Euros
National and
public
Health is one of the focus areas
4. The Vårdal Foundation Funds applied research Care science 4 million
Euros
National and
private
Specific focus on health
5. The Swedish Childhood
Cancer Foundation
Funds basic and applied research Clinical, epidemiological, biological, care
science, psychosocial
14 million
Euros
National and
private
Specific focus on abolishment of
childhood cancer
6. The Swedish Cancer Society Funds basic and applied research Clinical, epidemiological, pre-clinical,
translational, care science
40 million
Euros
National and
private
Specific focus on abolishment of
cancer
7. The County Council of
Uppsala
Funds applied research Clinical 18 million
Euros
Local and
public
Specific focus on clinical research
8. The County Council of
Västerbotten
Funds applied research Clinical 15 million
Euros
Local and
public
Specific focus on clinical research
9. The County Council of
Stockholm
Funds applied research Clinical 41 million
Euros
Local and
public
Specific focus on clinical research
10. Region Skånec Funds applied research Clinical 29 million
Euros
Local and
public
Specific focus on clinical research
aThe figures for the Education Council indicate how much resources they indirectly decide over, and the figures for other funders indicate how much they directly
allocate to clinical research on an annual basis. Funds from funders 2–3 and 7–10 are included in the resources that the Education Council decides over. The
figures are based on elaboration of statistics between 2008 and 2012
bCare science is mostly a Swedish definition and includes different disciplines such as nursing science, occupational therapy, psychosocial research, physiotherapy,
and rehabilitation
cRegion Skåne is officially a region but has in general the same functions and tasks as a County Council
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Funders roles in implementation
Regarding funders’ facilitative roles in relation to imple-
mentation, two common roles for two different funding
levels were identified: “Advocacy work” and “Monitor-
ing implementation outcomes” (Table 3). “Advocacy
work” was mentioned by one national public and three
national private funders. All four defined the role
“Advocacy work” in a similar manner but worked with
advocacy from different standpoints, for instance, the
national public funder stated that their role was to
communicate among decision-makers that implementa-
tion is important, whereas the national private funder
attempted to convince decision-makers to invest in im-
plementation and also saw their role as educating the
general public.
Two national private funders and one local public
funder considered that “Monitoring implementation
outcomes” is an important part of their work in relation
to implementation. The national private funders had a
structured way to monitor implementation outcomes
either through a yearly published report describing the
research results and their implementation or through
an updated register about treatments that had been
implemented and the outcomes for patients. “Dissemin-
ation of knowledge” was a role mentioned only by the
three private funders who described this in similar
terms, i.e., as something that goes beyond sending out
newsletters and publishing results on the internet. In
addition to these three common roles, the ten funders
mentioned five other roles: “Work actively towards im-
plementation,” “Create conditions for implementation
through legislation in implementation related issues,”
“Stimulate collaboration between researchers and in-
dustry,” “Educate healthcare personnel and parents,”
and “Create structures for organized introduction.” All
of these eight roles, except partly the role “Monitoring
implementation outcomes,” were presented as roles the
funders currently already fulfilled as the funders illus-
trated these with their concrete activities. The local
public funder who mentioned the role “Monitoring im-
plementation outcomes” did not illustrate this role with
specific activities and thus seemed more of a potential
role the funder could or should fulfill. On the other
hand, the two national private funders who mentioned
the role “Monitoring implementation outcomes” ex-
plained the role through concrete activities.
Table 2 Documents and sources reviewed in order to enhance the rigor of the study
Funder Type Description
The Research Council for Medicine and Health Website www.vr.se/amnesomraden/amnesomraden/medicinochhalsa.4.12fff4451215
cbd83e4800020161.html
The Research Council for Medicine and Health Goal statement Program statement 2013-2016
Sweden’s Innovation Agency (Vinnova) Website www.vinnova.se/en/
Sweden’s Innovation Agency (Vinnova) Annual report Years 2012 and 2013
The Vårdal Foundation Website www.vardal.se/topp-meny/in-english/
The Vårdal Foundation Annual report Years 2012 and 2013
The Swedish Childhood Cancer Foundation Website www.barncancerfonden.se/In-english/
The Swedish Childhood Cancer Foundation Annual report Years 2012 and 2013
The Swedish Cancer Society Website www.cancerfonden.se/sv/Information-in-English/
The Swedish Cancer Society Annual report Years 2012 and 2013
All County Councils Goal statement Contracta between the Swedish government and certain County Councils
concerning cooperation about education of physicians, medical research,
and development of health care
The County Council of Uppsala Goal statement Regional contract between the Uppsala University and the County Council
of Uppsala concerning cooperation about education of physicians, medical
research, and development of health care
The County Council of Västerbotten Goal statement Regional contract between the Umeå University and the County Council of
Västerbotten concerning cooperation about education of physicians, medical
research, and development of health care
The County Council of Stockholm Goal statement Regional contract between the County Council of Stockholm and the Karolinska
Institutet concerning cooperation about education of physicians, medical research,
and development of health care
Region Skåne Goal statement Regional contract between the Region Skåne and the Lund University
concerning cooperation about education of physicians, medical research,
and development of health care
aThis contract and its regional versions between County Councils and Universities are often called ALF contracts where ALF stands for “contract between the
Swedish government and certain County Councils concerning cooperation about education of physicians, medical research, and development of health care”
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Responsibility for implementation?
The funders identified six different actors responsible for
implementation. Table 4 provides the list of these actors.
The “County Councils” (three funders from three dif-
ferent levels), followed by the “Head of hospital units”
(three funders from two different levels), were the actors
most often pinpointed as responsible for implementa-
tion. The key role of the County Councils was further
underlined by the fact that one more funder viewed
them as responsible together with other actors, namely
medical practitioners. The national public funders
agreed in general that it is the County Councils, alone or
in concert with other actors, who are responsible for im-
plementation. Similarly, national private funders leaned
towards the County Councils and the “Head of hospital
units” as responsible actors, with the exception of one
private funder who stated that it is the research funders
together with researchers who are responsible for imple-
mentation. Also, the local public funders considered that
the County Councils or actors within the County Coun-
cils are responsible for implementation. Consequently,
the majority of the funders considered that the responsi-
bility for implementation is located in the healthcare
setting and preferably shouldered by the County Coun-
cils or actors within County Councils.
Do the identified actors take responsibility for
implementation?
The majority of the funders who considered that County
Councils are responsible for implementation stated that
these take responsibility for implementation of clinical
research results “To a certain degree.” For this incom-
plete responsibility taking, two explanations were pro-
posed: (1) the County Councils’ systems for bringing
clinical research results into practice are not really clear
and (2) the County Councils’ focus on saving lives and
cost control do not always ease implementation of new
findings. A more negative view was taken by one na-
tional private funder who considered that the County
Councils are not organizationally capable of taking such
responsibility. The majority of the funders selecting the
option “Head of hospital units” considered that this
actor takes responsibility, whereas a minority stated that
this actor takes responsibility “To a certain degree.” In
general, five funders considered that the actors they
identified take responsibility “To a certain degree,” four
Table 3 Research funder (N = 10) roles in relation to the implementation of clinical research results
Research fundera roles Definition of funder roles National public
(N = 3)
National private
(N = 3)
Local public
(N = 4)
Total funding
levelsb
1. Advocacy work Aims to create awareness and increase knowledge
among decision-makers at different levels through
different means about feasibility and costs of
implementation of clinical research results
1 funderc 3 funders 4 funders
2. Monitoring implementation
outcomes
Follows-up, evaluates, and reports the results
of implementation of clinical research results
regarding outcomes and costs
2 funders 1 funder 3 funders
3. Dissemination of knowledge Through different means spread information
about clinical research results
3 funders 3 funders
4. Work actively towards
implementation
Is engaged and takes responsibility during
the whole research process from research
start to receiving of output and is prepared
to adjust the plans during the process
1 funder 1 funder
5. Create conditions for
implementation through
legislation in implementation
related issues
Enables for the healthcare professionals to
get access to the state of the art knowledge
by establishing organizations that can
produce guidelines
1 funder 1 funder
6. Stimulate collaboration
between researchers and
industry
Organizes research projects which demand
involvement of private companies that are
going to use the output of the project
1 funder 1 funder
7. Educate healthcare personnel
and parents to patients
Organizes education of healthcare personnel
and parents to children suffering from cancer
1 funder 1 funder
8. Create structures for organized
introduction
Redesigns health care providing organizations
so that they are capable of integrating new
clinical research results in healthcare practice
1 funder 1 funder
Total funder rolesd 3 roles 5 roles 2 roles
aMultiple roles per funder allowed
bSummarizes the amount of funders supporting each role horizontally across funding levels. NB: the sum of these totals is higher than 10, due to multiple
answers allowed per funder
cIndicates the amount of funders supporting each role
dSummarizes the amount of roles vertically for funders within each funding level
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funders thought that the identified actors take responsi-
bility and one funder considered that the identified actor
does not take responsibility (Table 4). As shown in
Table 5, half of the funders considered that no one else
should take responsibility for implementation, followed
by three funders who thought that someone else should
take responsibility “To a certain degree” and two funders
who considered that someone else should take responsi-
bility. A more detailed description of the findings can be
found in Additional file 4.
Discussion
“Advocacy work,” “Monitoring implementation out-
comes,” and “Dissemination of knowledge” are the three
most popular roles. “Advocacy work,” supported by two
funding levels is an acknowledged role for funders [11].
“Monitoring implementation outcomes,” supported also
by two funding levels, is about activities occurring after
implementation and is not reported in previous research
regarding funders but is well documented in policy and
program implementation contexts [28–30]. Also, “Dis-
semination of knowledge,” supported by only three pri-
vate national funders, is reported in previous research
[15, 17]. The majority of the funders consider that the
actual responsibility for implementation lies in the
healthcare setting. However, five funders express that
the actors they identify take responsibility “To a certain
degree,” which implies that although the funders identify
the actors responsible for implementation they are not en-
tirely convinced that the identified actors actually take re-
sponsibility. Despite this, five out of ten funders consider
that no one else should take responsibility for implementa-
tion of clinical research results and only two out of ten ex-
press that someone else should do that. The fact that
funders from the three funding levels together propose five
different County Council-related actors as responsible for
implementation is not surprising as the “problem of many
hands” suggests that in complex organizations, it might be
difficult to state who actually is responsible [20]. Further-
more, the majority of the funders refer either to a group of
Table 4 Who is responsible for implementation of clinical research results and do these actors take responsibility?
Actors identified and perceived
responsibility takinga
National public
(N = 3)
National private (N = 3) Local public (N = 4) Total funding levelsb
1. County Councils 1 funderc Somewhatd
(1 funder)
1 funder No (1 funder) 1 funder Somewhat
(1 funder)
3 funders Somewhat
(2 funders), No (1 funder)
2. Head of hospital units 1 funder Yes (1 funder) 2 funders Yes (1 funder),
Somewhat (1 funder)
3 funders Yes (2 funders),
Somewhat (1 funder)
3. Healthcare system 1 funder Somewhat
(1 funder)
1 funder Somewhat
(1 funder)
4. Medical practitioners together
with County Councils
1 funder Somewhat
(1 funder)
1 funder Somewhat
(1 funder)
5. Research funders together
with the researcher
1 funder Yes (1 funder) 1 funder Yes (1 funder)
6. Hospital leadership 1 funder Yes (1 funder) 1 funder Yes (1 funder)
Total funderse 3 actors Somewhat
(3 funders)
3 actors Yes (2 funders),
No (1 funder)
3 actors Somewhat
(2 funders), Yes (2 funders)
10 funders Somewhat
(5 funders), No (1 funder),
Yes (4 funders)
aOne answer per funder allowed
bSummarizes the total amount of funders suggesting each responsible actor across funding levels (N = 10) and the responsibility alternatives across funding levels
where the possible alternatives are “Yes,” “To a certain degree,” and “No.” The amount of funders, regarding each responsibility alternative, is given in brackets
cThe amount of funders within funding levels suggesting each responsible actor is indicated, followed by views on responsibility taking and the amount of
funders indicating each view, which is given in brackets
dSomewhat stands for “To a certain degree”
eSummarizes the amount of identified actors by funders and responsibility alternatives vertically for funders within each funding level. The amount of funders,
regarding each responsibility alternative, is given in brackets
Table 5 Should someone else take responsibility for implementation of clinical research results?
Should someone else take responsibility?a National public
(N = 3)
National private
(N = 3)
Local public (N = 4) Totalb
Yes 1 funderc 1 funder 2 funders
To a certain degree 1 funder 2 funders 3 funders
No 1 funder 3 funders 1 funder 5 funders
aOnly one answer per funder allowed
bIndicates the total amount of funders across funding levels supporting each option where the possible alternatives are “Yes,” “To a certain degree,” and
“No” (N = 10)
cIndicates the amount of funders within funding levels supporting each option
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actors (actor 6 in Table 4), to organizations (actors 1 and 3
in Table 4), or to a combination of actors and organizations
(actor 4 in Table 4) which entails either collective or
organizational responsibility [23]. Prevalence of collective
and organizational responsibility together with the fact
that it is difficult for funders to identify actors responsible
for implementation indicates that in complex healthcare
organizations, responsibility for implementation risks
becoming no one’s responsibility (see Additional file 5 for
a detailed discussion).
Study limitations
This study utilized an explorative approach in studying
funders’ roles and perceived responsibilities in relation
to implementation, as these issues were assumed to be
rather new for many funders. Consequently, it was not
deemed appropriate to send out a questionnaire to all
clinical research funders that could have opened up for a
quantitative analysis. An alternative method could have
been an in-depth study of one or few implementation
cases, focusing on the roles of funders and other actors
in action. This method could have captured the mecha-
nisms and roles of all involved actors (funders, actors re-
sponsible for implementation, and implementers) and
their perceptions about their own and the funders’ roles
but would not have provided a representative picture of
the Swedish research funding system. Instead, the deci-
sion to obtain a complete picture of clinical research
funders in Sweden, using a representative sample as for
resources and geographical scope, was chosen. More-
over, the selected approach covered three important
funding levels.
Conclusions and implications
“Advocacy work,” “Monitoring implementation outcomes,”
and “Dissemination of knowledge” are common roles for
Swedish research funders. “Monitoring implementation out-
comes” is not reported in previous research. The Swedish
research funders identify six different actors responsible for
implementation, indicating difficulties to state the actors
responsible for implementation in accordance with the
“problem of many hands.” Moreover, the existence of a
“problem of many hands” is supported by the finding that
the prevalent form of responsibility is either collective or
organizational responsibility. These findings together
imply that in complex healthcare organizations, imple-
mentation risks become no one’s responsibility. This find-
ing has bearing not only for healthcare providers when
they are planning and conducting implementation but also
for funders who wish to facilitate implementation in dif-
ferent ways, as well as for funders of funders who allocate
resources to clinical research aiming to improve public
health. Our findings have implications also for implemen-
tation researchers demonstrating the relevance of studying
funders’ roles and responsibility issues in relation to im-
plementation and thus justifying the necessity of a broader
scope in order to understand implementation and the
steps leading to it.
Additional files
Additional file 1: Description of the three funding levels. This file
describes the selected funders and connects them with the funding levels.
Additional file 2: Summarized interview guide. This file presents a
summarization of the questions posed to the respondents.
Additional file 3: Detailed description of the methods. This file
describes more thoroughly the methods applied.
Additional file 4: Detailed description of the findings. This file
describes more thoroughly the findings.
Additional file 5: Detailed discussion of the findings. This file
discusses more thoroughly the findings.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
AB, EB, and UW designed and planned the study. AB was responsible for the
study conduct. AB, EB, UW, and TvA contributed to the analysis and
interpretation of the data. All authors have been involved in drafting the
manuscript and approved the final manuscript.
Acknowledgements
We acknowledge U-CARE research program at the Uppsala University, who
funded this study together with the Medical Faculty at the Uppsala University
and Handelsbanken’s Research Foundation.
Author details
1Department of Public Health and Caring Sciences, Uppsala University,
Uppsala, Sweden. 2Department of Industrial Engineering and Management,
Uppsala University, Uppsala, Sweden. 3Centre for Health Services and Nursing
Research, KU Leuven, Leuven, Belgium.
Received: 12 February 2015 Accepted: 7 July 2015
References
1. Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice: a
systematic review of rigorous evaluations. Lancet. 1993;342:1317–22.
2. Emanuel EJ. What makes clinical research ethical? JAMA. 2000;283:2701.
3. Grimshaw JM, Eccles MP, Lavis JN, Hill SJ, Squires JE. Knowledge translation
of research findings. Implement Sci. 2012;7:50.
4. Grimshaw JM, Thomas RE, MacLennan G, et al. Effectiveness and efficiency
of guideline dissemination and implementation strategies. Heal Technol
Assess. 2004;8.
5. Abraham C, Michie S. A taxonomy of behavior change techniques used in
interventions. Heal Psychol. 2008;27:379–87.
6. Flottorp SA, Oxman AD, Krause J, et al. A checklist for identifying
determinants of practice: a systematic review and synthesis of frameworks
and taxonomies of factors that prevent or enable improvements in
healthcare professional practice. Implement Sci. 2013;8:35.
7. Grol RPTM, Bosch MC, Hulscher MEJL, Eccles MP, Wensing M. Planning and
studying improvement in patient care: the use of theoretical perspectives.
Milbank Q. 2007;85:93–138.
8. Kessler R, Glasgow RE. A proposal to speed translation of healthcare
research into practice: dramatic change is needed. Am J Prev Med.
2011;40:637–44.
9. Green LW, Glasgow RE, Atkins D, Stange KC. Getting evidence from
science to practice: slips “twixt cup and lip.”. Am J Prev Med. 2009;37
Suppl 1:S187–91.
10. Wensing M, Bal R, Friele R. Knowledge implementation in healthcare
practice: a view from The Netherlands. BMJ Qual Saf. 2012;21:439–42.
Brantnell et al. Implementation Science  (2015) 10:100 Page 7 of 8
11. Holmes B, Scarrow G, Schellenberg M. Translating evidence into practice:
the role of health research funders. Implement Sci. 2012;7:39.
12. Bekker M, van Egmond S, Wehrens R, Putters K, Bal R. Linking research and
policy in Dutch healthcare: infrastructure, innovations and impacts. Evid
Policy. 2010;6:237–53.
13. Graham ID, Tetroe JM. Getting evidence into policy and practice:
perspective of a health research funder. J Can Acad Child Adolesc
Psychiatry. 2009;18:46–50.
14. Kerner JF. Knowledge translation versus knowledge integration: a “funder’s”
perspective. J Contin Educ Health Prof. 2006;26:72–80.
15. Lomas J. Using “linkage and exchange” to move research into policy at a
Canadian Foundation. Health Aff. 2000;19:236–40.
16. Smits PA, Denis J-L. How research funding agencies support science
integration into policy and practice: an international overview. Implement
Sci. 2014;9:28.
17. Tetroe JM, Graham ID, Foy R, et al. Health research funding agencies’
support and promotion of knowledge translation: an international study.
Milbank Q. 2008;86:125–55.
18. Prasad V, Ioannidis JP. Evidence-based de-implementation for contradicted,
unproven, and aspiring healthcare practices. Implement Sci. 2014, 9.
19. Holmes BJ, Schellenberg M, Schell K, Scarrow G. How funding agencies
can support research use in healthcare: an online province-wide survey
to determine knowledge translation training needs. Implement Sci.
2014;9:71.
20. Thompson DF. Moral responsibility of public officials: the problem of many
hands. Am Polit Sci Rev. 1980;74:905–16.
21. Braithwaite J, Makkai T. Testing an expected utility model of corporate
deterrence. Law Soc Rev. 1991;25:7–40.
22. Jackall R. Moral mazes: the world of corporate managers. 20th ed. New
York: Oxford University Press; 2010.
23. Bovens M. The quest for responsibility. Accountability and citizenship in
complex organisations. Cambridge: Cambridge University Press; 1998.
24. Denzin N. The research act in sociology: a theoretical introduction to
sociological methods. London: Butterworths; 1970.
25. Dubois A, Gadde L-E. Systematic combining: an abductive approach to case
research. J Bus Res. 2002;55:553–60.
26. Shah R, Goldstein SM, Unger BT, Henry TD. Explaining anomalous high
performance in a health care supply chain. Decis Sci. 2008;39:759–89.
27. Yin RK. Case study research: design and methods. 3rd ed. SAGE: Thousand
Oaks; 2003.
28. Weissert CS. Reluctant partners: the role of preferences, incentives, and
monitoring in program compliance. J Public Adm Res Theory.
2001;11:435–53.
29. López-Acevedo G, Saavedra Chanduvi J, editors. Building better policies:
nuts and bolts of government monitoring and evaluation systems.
Washington D.C.: World Bank Publications; 2012.
30. Segone M, editor. Bridging the gap: the role of monitoring and evaluation
in evidence-based policy making. New York, NY: UNICEF; 2010.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Brantnell et al. Implementation Science  (2015) 10:100 Page 8 of 8
